ArticleNature nanotechnology2026
Enzymatic microbubble robots.
Article in Nature nanotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Nitric-oxide propelled nanomotors sensitize tumors to ferroptosis immunotherapy via cholesterol depletion-induced tumor cells stiffening.Materials today. Bio · 2026Article
- Strain-insensitive wet-tissue-adhesive biphasic bioelectronics for physicochemical monitoring and adaptive therapy.Nature materials · 2026Article
- Stretchable quantum dot displays achieve high definition.Nature nanotechnology · 2026Article
- Living Inorganic Nanomaterials: Design, Preparation, and Biomedical Applications.Advanced materials (Deerfield Beach, Fla.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
The development of micro- and nanorobots has amplified the demand for intelligent multifunctional machines in biomedical applications, but most microrobotic systems struggle to achieve the attributes needed for those applications. Here we introduce enzymatic microbubble robots that exhibit steerable motion, enhanced biodegradability, high in vivo imaging contrast, and effective targeting and penetration of disease sites. These microrobots feature natural protein shells modified with urease to decompose bioavailable urea for autonomous propulsion, whereas an internal microbubble serves as an ultrasound imaging contrast agent for deep tissue imaging and navigation. Magnetic nanoparticle integration enables imaging-guided magnetically controlled motion and catalase functionalization facilitates chemotactic movement towards hydrogen peroxide gradients, directing robots to tumour sites. Focused ultrasound triggers robot shell collapse and inertial cavitation of the released microbubbles, creating mechanical forces that enhance therapeutic payload penetration. In vivo studies validate the tumour-targeting and therapeutic efficacy of these robots, demonstrating enhanced antitumour effects. This multifunctional microbubble robotic platform has the potential to transform medical interventions and precision therapies.
Indexed as
Identifiers
41629479What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.